Oral bioavailability of MEDI7219 tablets Oral tablet formulation Tablets contained 0.510 mg of MEDI7219, 150 mg of permeation enhancers (50 mg NaCDC [Prodotti, Basaluzzo, Italy] and 100 mg PG [Guangzhou Hanfang Pharmaceutical, Guangzhou, China]), mannitol (Roquette, Keokuk, IA, USA) as filler, crospovidone (BASF, Ludwigshafen, Germany) as disintegrant, sodium stearyl fumarate (JRS Pharma, Rosenberg, Germany) as lubricant and hydrophobic fumed silica (Evonik, Parsippany, NJ, USA) as glidant, with a total weight of 245 mg per tablet
Metabolomics (2020) 16(1):10
[Clinical observation on effect of total glucosides of paeony combined with methotrexate on rheumatoid arthritis]
Pacheco, L
Neas LM, Dockery DW, Ware JH, Spengler JD, Speizer FE, & Ferris BG Jr (1991) Association of indoor nitrogen dioxide with respiratory symptoms and pulmonary function in children
Tranexamic Acid Pill for Melasma Melasma Treatment with Oral Tranexamic Acid Melasma is a skin condition that causes hyperpigmented patches or spots on the skin
